FMR LLC 13D and 13G filings for Enliven Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-06 10:20 am Purchase | 2026-06-30 | 13G | ENLIVEN THERAPEUTICS INC ELVN | FMR LLC | 10,713,540 15.000% | 2,843,321 (+36.13%) | Filing |
| 2025-11-05 11:35 am Purchase | 2025-09-30 | 13G | ENLIVEN THERAPEUTICS INC ELVN | FMR LLC | 7,870,219 13.300% | 1,967,954 (+33.34%) | Filing |
| 2024-02-09 09:03 am Purchase | 2024-02-08 | 13G | ENLIVEN THERAPEUTICS INC ELVN | FMR LLC | 5,902,265 14.321% | 1,482,684 (+33.55%) | Filing |
| 2023-05-10 09:45 am Purchase | 2023-05-09 | 13G | ENLIVEN THERAPEUTICS INC ELVN | FMR LLC | 4,419,581 10.749% | 4,003,554 (+962.33%) | Filing |